Quick Answer
EVO ICL surgery in the United States typically costs between $3,500 and $5,500 per eye, with most patients paying $4,000 to $4,500 per eye. The national average for both eyes is approximately $8,000 to $9,000 all-in. This price is higher than LASIK because the EVO ICL procedure involves an implanted medical device, greater surgical complexity, and more extensive preoperative testing.
Detailed Explanation
The cost of EVO ICL surgery is not uniform across practices or geographic regions. Understanding what drives the price — and what is or is not included — is essential before comparing quotes from multiple providers.
What the price typically includes:
A comprehensive EVO ICL quote from a reputable practice should include:
- All preoperative candidacy testing (corneal topography, pachymetry, biometry, anterior segment OCT)
- The EVO ICL lens itself (the single largest cost component)
- Surgeon fees
- Facility or operating room fees
- Anesthesia (topical; no additional anesthesiologist is typically required)
- Immediate postoperative care on the day of surgery
- Standard follow-up visits (usually at 1 day, 1 week, 1 month, and 3 months post-surgery)
What is often excluded:
Some practices advertise a lower “starting from” price that excludes the lens cost, enhancement fees, or extended follow-up care. Always ask for an itemized quote that specifies exactly what is and is not included through the global care period.
Why EVO ICL costs more than LASIK:
LASIK averages $2,000 to $3,000 per eye nationally. EVO ICL costs more for three primary reasons:
1. The device cost. The EVO ICL lens is a precision-manufactured medical implant that costs the practice significantly more than the consumables used in laser surgery. 2. Surgical complexity. EVO ICL is an intraocular procedure — it involves entering the eye — which requires greater surgical skill and a sterile operating environment comparable to cataract surgery. 3. Sizing and planning. Accurate lens sizing requires advanced imaging equipment and specialized expertise. Errors in sizing can necessitate lens exchange, so practices invest heavily in preoperative measurement protocols.
Geographic variation:
Cost varies meaningfully by region. Major metropolitan areas — New York, Los Angeles, Miami, San Francisco — tend to price at the higher end of the range. Markets in the Southeast, Midwest, and Mountain West typically come in lower. However, lower price does not indicate lower quality. Surgeon experience and practice infrastructure are more meaningful indicators than geography.
The surgeon experience factor:
A surgeon who has performed 2,000 EVO ICL procedures may charge more than one who has performed 200. That premium is often justified. Published outcomes data consistently shows that higher-volume surgeons have lower complication rates and more accurate visual results. When evaluating cost, weigh total outcome probability — not just the upfront number.
For a directory of recognized high-volume EVO ICL surgeons, visit the EVO ICL Awards page.
Important Considerations
Insurance does not cover EVO ICL. The procedure is classified as elective refractive surgery by every major insurance carrier in the United States. However, several financial pathways exist to make the procedure accessible.
Financing options:
- CareCredit and Alphaeon Credit are the two most widely accepted third-party financing platforms in ophthalmology. Both offer promotional 0% APR periods ranging from 12 to 24 months, subject to credit approval.
- In-house payment plans are offered by many practices, particularly larger groups that do high procedure volume.
- Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) can be used to pay for EVO ICL surgery with pre-tax dollars. This effectively reduces your out-of-pocket cost by your marginal tax rate — a meaningful discount for many patients.
Beware of discount pricing:
Practices advertising EVO ICL at $2,500 per eye or less should be scrutinized carefully. At that price point, something is typically excluded — whether it is the lens cost, follow-up care, or enhancement coverage. In some cases, a significantly lower price reflects a surgeon with limited EVO ICL-specific experience. Given that EVO ICL is an intraocular surgery, selecting a provider primarily on price is a particularly high-risk approach.
Enhancement rates:
Most experienced surgeons achieve target refraction within ±0.5D on the first procedure. Some patients require minor enhancement — either an ICL exchange for a different power lens or supplemental laser treatment. Ask prospective surgeons about their enhancement rate and whether enhancement is included in the initial fee.
What to Do Next
Request itemized quotes from at least two or three practices. Confirm that each quote covers the same scope — preoperative testing, the lens, surgery, and all standard follow-up visits through the global period (typically 90 days post-op).
Ask each practice specifically: 1. What is the lens manufacturer? (Should be STAAR Surgical’s EVO ICL, not an older ICL model) 2. How many EVO ICL procedures has the surgeon performed in the past 12 months? 3. Is enhancement included if target refraction is not achieved?
Review Does Insurance Cover EVO ICL? for a detailed look at insurance policy language and how to maximize HSA/FSA benefits for this procedure.
Related Questions
What does LASIK cost by comparison? If you are evaluating procedures side by side on cost alone, see Is EVO ICL Better Than LASIK? for a full cost-benefit analysis.
How do I find a qualified surgeon without overpaying? See How Do I Find the Best EVO ICL Surgeon? for criteria that go beyond price.
Does my prescription qualify? Cost is irrelevant if you are not a candidate. Start with Who Is Not a Good Candidate for EVO ICL? to screen for disqualifying factors.